Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review

Arch Iran Med. 2020 Oct 1;23(10):713-717. doi: 10.34172/aim.2020.92.

Abstract

The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.

Keywords: COVID-19; Liver disease; liver transplantation.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / therapy
  • Humans
  • Infection Control*
  • Liver Diseases / complications
  • Liver Diseases / mortality
  • Liver Diseases / surgery*
  • Liver Transplantation*
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / therapy
  • SARS-CoV-2